AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23577619 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin and chloroquine fixed-dose combination (AZCQ)
Number of subjects: 1000
Study 23577619 — intervention group
Group type: COMPARATOR
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 1000
Study 21505361 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus rhamnosus strain GG (12 billion CFU/day) for 8 weeks
Number of subjects: 20
Study 21505361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19740297 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (0.2 mg/kg/day) for 12 months
Number of subjects: 76
Study 19740297 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 76
Study 17845655 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricothyroidotomy on manikin
Number of subjects: 70
Study 17845655 — intervention group
Group type: COMPARATOR
Intervention: Cricothyroidotomy on simulator
Number of subjects: 70
Study 16782975 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon 50-70%
Number of subjects: 39
Study 16782975 — intervention group
Group type: COMPARATOR
Intervention: Propofol 3-5 mg kg(‐1) h(‐1)
Number of subjects: 39
Study 16782975 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessment
Number of subjects: 39
Study 15387358 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide plus metronidazole and ciprofloxacin
Number of subjects: 0
Study 15387358 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 0
Study 10923605 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nasal azelastine (two sprays BID)
Number of subjects: 24
Study 8833208 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/day for 3 years
Number of subjects: 516
Study 8833208 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/day for 3 years
Number of subjects: 516
Study 8833208 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 20 mg/day for 2 years followed by 5 mg/day for the 3rd year
Number of subjects: 516
Study 8833208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 516
Study 1435173 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric resistance training of the knee extensors (30 MVC.d‐1 x 3 d.wk‐1 x 8 wk)
Number of subjects: 15
Study 1435173 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric resistance training of the knee extensors
Number of subjects: 15
Study 1435173 — intervention group
Group type: COMPARATOR
Intervention: Untrained legs of experimental subjects and both legs of control subjects
Number of subjects: 15
Study 3911964 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 300 mg suppositories
Number of subjects: 61
Study 3911964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 3911964 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen
Number of subjects: 61
Study 31627016 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccination (PCV)
Number of subjects: 800
Study 31627016 — intervention group
Group type: COMPARATOR
Intervention: Pneumococcal polysaccharide vaccine (PPV)
Number of subjects: 800
Study 28679552 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber diet (≥18 g NSP/d)
Number of subjects: 166
Study 28679552 — intervention group
Group type: COMPARATOR
Intervention: Habitual-fiber diet (control)
Number of subjects: 166
Study 26024293 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholemeal bread
Number of subjects: 22
Study 26024293 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacar bread
Number of subjects: 22
Study 26024293 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary bread
Number of subjects: 22
Study 26024293 — intervention group
Group type: EXPERIMENTAL
Intervention: Precooked-Frozen bread
Number of subjects: 22
Study 26024293 — intervention group
Group type: EXPERIMENTAL
Intervention: Candeal-flour bread
Number of subjects: 22
Study 26024293 — intervention group
Group type: COMPARATOR
Intervention: Glucose (reference)
Number of subjects: 22
Study 21950319 — intervention group
Group type: EXPERIMENTAL
Intervention: High power individuals in low group status condition
Number of subjects: 0
Study 21950319 — intervention group
Group type: EXPERIMENTAL
Intervention: High power individuals in high group status condition
Number of subjects: 0
Study 21950319 — intervention group
Group type: EXPERIMENTAL
Intervention: High power individuals made accountable for group goals
Number of subjects: 0
Study 21950319 — intervention group
Group type: EXPERIMENTAL
Intervention: High power individuals in both experiments
Number of subjects: 0
Study 22136015 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture applied to Shenshu (BL 23), Pishu (BL 20), Zusanli (ST 36), and Sanyinjiao (SP 6) for 6 sessions.
Number of subjects: 60
Study 22136015 — intervention group
Group type: COMPARATOR
Intervention: Blank control group (no intervention).
Number of subjects: 60
Study 18510043 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 18510043 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 0
Study 17668564 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI (efavirenz; EFV)
Number of subjects: 120
Study 17668564 — intervention group
Group type: EXPERIMENTAL
Intervention: non-boosted PI (nelfinavir; NFV)
Number of subjects: 120
Study 17668564 — intervention group
Group type: EXPERIMENTAL
Intervention: NNRTI + PI (EFV/NFV)
Number of subjects: 120
Study 17668564 — intervention group
Group type: COMPARATOR
Intervention: All arms
Number of subjects: 120
Study 15189781 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg daily)
Number of subjects: 20
Study 15189781 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg daily)
Number of subjects: 20
Study 11349017 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 x 10(10) HWC plus 25 microg of LT(R192G)
Number of subjects: 41
Study 11349017 — intervention group
Group type: COMPARATOR
Intervention: Placebo-vaccine plus 25 microg of LT(R192G)
Number of subjects: 41
Study 11349017 — intervention group
Group type: COMPARATOR
Intervention: Placebo-vaccine plus placebo-adjuvant
Number of subjects: 41
Study 11349017 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 x 10(10) HWC plus placebo-adjuvant
Number of subjects: 41
Study 11349017 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 8997460 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular meperidine (0.75 mg/kg) at gluteal site
Number of subjects: 14
Study 8997460 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular meperidine (0.75 mg/kg) at deltoid site
Number of subjects: 14
Study 8997460 — intervention group
Group type: COMPARATOR
Intervention: Both injection sites (gluteal and deltoid)
Number of subjects: 14
Study 7700051 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe subgroup (patients requiring amputation or developed necrosis)
Number of subjects: 12
Study 7700051 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild subgroup (patients receiving conservative treatment of thrombectomy)
Number of subjects: 12
Study 7700051 — intervention group
Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 12
Study 7700051 — intervention group
Group type: EXPERIMENTAL
Intervention: Diseased group
Number of subjects: 12
Study 7700051 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe subgroup
Number of subjects: 12
Study 7700051 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild subgroup
Number of subjects: 12
Study 3499161 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental propofol
Number of subjects: 60
Study 3499161 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 60
Study 3499161 — intervention group
Group type: COMPARATOR
Intervention: Non-anaesthetized control group
Number of subjects: 60
Study 31873788 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bout of whole-body resistance exercise (seven exercises, three sets, 10-12 repetitions at 80% of one-repetition maximum)
Number of subjects: 10
Study 31873788 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bout of whole-body resistance exercise
Number of subjects: 10
Study 29664983 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (Lucentis; Genentech) monotherapy
Number of subjects: 30
Study 29664983 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab plus peripheral laser (combination therapy)
Number of subjects: 30
Study 29664983 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 30
Study 27196104 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 130/0.42
Number of subjects: 654
Study 27196104 — intervention group
Group type: COMPARATOR
Intervention: Ringer's acetate
Number of subjects: 654
Study 26386793 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 10 mg/d (5 mg/d for patients ≥75 years and/or <60 kg)
Number of subjects: 9326
Study 26386793 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg/d
Number of subjects: 9326
Study 23143846 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed messages
Number of subjects: 538
Study 23143846 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-detailed messages
Number of subjects: 538
Study 20818480 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light (2500 lux) during breaks
Number of subjects: 94
Study 20818480 — intervention group
Group type: COMPARATOR
Intervention: Normal light (300 lux) during breaks
Number of subjects: 94
Study 19082803 — intervention group
Group type: EXPERIMENTAL
Intervention: Tang No.1 granule (T1G) for 6 months
Number of subjects: 140
Study 19082803 — intervention group
Group type: COMPARATOR
Intervention: Control group (general knowledge about IGT)
Number of subjects: 140
Study 17159259 — intervention group
Group type: EXPERIMENTAL
Intervention: He-Ne laser therapy (wavelength 632.8 nm, output 10mW)
Number of subjects: 50
Study 17159259 — intervention group
Group type: COMPARATOR
Intervention: Oral analgesics, local application of anaesthetics, 0.9% saline, and povidine wash
Number of subjects: 50
Study 15386794 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention group (n=69)
Number of subjects: 102
Study 15386794 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=33)
Number of subjects: 102
Study 10862636 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg)
Number of subjects: 8
Study 10862636 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg)
Number of subjects: 8
Study 10862636 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide 5 mononitrate (40 mg)
Number of subjects: 8
Study 10862636 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (Losartan and Enalapril)
Number of subjects: 8
Study 9043272 — intervention group
Group type: EXPERIMENTAL
Intervention: J-pouch irrigations through the efferent ileostomy stoma, daily for 4 weeks.
Number of subjects: 58
Study 9043272 — intervention group
Group type: COMPARATOR
Intervention: Kegel exercises (anal muscle strengthening exercises) taught to both groups.
Number of subjects: 58
Study 9043272 — intervention group
Group type: COMPARATOR
Intervention: Control group (no J-pouch irrigation).
Number of subjects: 58
Study 1574953 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotropin-releasing hormone (400 micrograms iv)
Number of subjects: 10
Study 1574953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2862223 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant oophorectomy followed by chemotherapy with cyclophosphamide, methotrexate, 5‐fluorouracil, and prednisone (CMFp)
Number of subjects: 327
Study 2862223 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy with cyclophosphamide, methotrexate, 5‐fluorouracil, and prednisone (CMFp) alone
Number of subjects: 327
Study 30529886 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (50 g)
Number of subjects: 16
Study 30529886 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (50 g)
Number of subjects: 16
Study 30529886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose (50 g)
Number of subjects: 16
Study 30529886 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralose (0.33 g)
Number of subjects: 16
Study 30529886 — intervention group
Group type: COMPARATOR
Intervention: Control (300 mL plain tap water)
Number of subjects: 16
Study 29150384 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-motor training (SMT), performed 5 times each week for 2 weeks
Number of subjects: 40
Study 29150384 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory-motor training (SMT)
Number of subjects: 40
Study 27146650 — intervention group
Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry (MC) juice (60 mL)
Number of subjects: 15
Study 27146650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 24963007 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with defibrillator (CRT-D)
Number of subjects: 537
Study 24963007 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter defibrillator therapy (control)
Number of subjects: 537
Study 22407383 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 132
Study 22407383 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 132
Study 20105186 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone (Ox) 0.03 mg/kg per day
Number of subjects: 133
Study 20105186 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone (Ox) 0.06 mg/kg per day
Number of subjects: 133
Study 20105186 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 133
Study 18164847 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT and thalidomide
Number of subjects: 332
Study 18164847 — intervention group
Group type: COMPARATOR
Intervention: WBRT alone
Number of subjects: 332
Study 15936184 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 9 microg
Number of subjects: 30
Study 15936184 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 18 microg
Number of subjects: 30
Study 15936184 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol/budesonide combination 9/320 microg
Number of subjects: 30
Study 14668418 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 0
Study 14668418 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 0
Study 14668418 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 0
Study 29162214 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin/ezetimibe fixed-dose combination (FDC; 10 mg/10 mg)
Number of subjects: 0
Study 29162214 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin/ezetimibe single agents (10 mg/10 mg)
Number of subjects: 0
Study 9094892 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (294 mg vitamin E, 1000 mg vitamin C, and 60 mg ubiquinone daily)
Number of subjects: 8
Study 9094892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 9094892 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 8
Study 7901257 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapiprazole 0.5%
Number of subjects: 48
Study 7901257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 3541168 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 110
Study 3541168 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinoril (sulindac)
Number of subjects: 110
Study 3541168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 3541168 — intervention group
Group type: COMPARATOR
Intervention: Clinoril and Placebo
Number of subjects: 110
Study 31184796 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-ended group intervention based on a cognitive behavioural therapy for insomnia self-help book
Number of subjects: 40
Study 31184796 — intervention group
Group type: COMPARATOR
Intervention: Care as usual/wait-list control condition
Number of subjects: 40
Study 31184796 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of the book and the open-ended group intervention
Number of subjects: 40
Study 30134847 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemocontrol hemodialysis
Number of subjects: 29
Study 30134847 — intervention group
Group type: COMPARATOR
Intervention: Standard hemodialysis
Number of subjects: 29
Study 27780198 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention (IPC, MM, CM, PA)
Number of subjects: 500
Study 27780198 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition counseling with less intensive MM, CM, and PA
Number of subjects: 500
Study 24285284 — intervention group
Group type: EXPERIMENTAL
Intervention: Udenafil 50 mg
Number of subjects: 60
Study 24285284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22933818 — intervention group
Group type: EXPERIMENTAL
Intervention: Frightening music
Number of subjects: 10
Study 20830219 — intervention group
Group type: EXPERIMENTAL
Intervention: EPBD with long ballooning time (60 seconds)
Number of subjects: 70
Study 20830219 — intervention group
Group type: EXPERIMENTAL
Intervention: EPBD with short ballooning time (20 seconds)
Number of subjects: 70
Study 18162935 — intervention group
Group type: COMPARATOR
Intervention: Killed oral cholera vaccine (mass immunization of older children and adults)
Number of subjects: 89596
Study 18162935 — intervention group
Group type: COMPARATOR
Intervention: Vaccine coverage of adult women
Number of subjects: 89596
Study 16416356 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological training programme (12 sessions over 4 weeks)
Number of subjects: 19
Study 16416356 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological training programme
Number of subjects: 19
Study 16416356 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 19
Study 12524408 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 20
Study 12524408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11961609 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Heller's myotomy and Dor's fundoplication
Number of subjects: 30
Study 11961609 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic dilation
Number of subjects: 30
Study 10430720 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 53
Study 10430720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle Ergometry Training (CET)
Number of subjects: 53
Study 10430720 — intervention group
Group type: EXPERIMENTAL
Intervention: CET + IMT
Number of subjects: 53
Study 10430720 — intervention group
Group type: COMPARATOR
Intervention: Health Education (ED)
Number of subjects: 53
Study 7477166 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine (liothyronine sodium) administered as an intravenous bolus of 0.8 microgram per kilogram of body weight and then as an infusion of 0.113 microgram per kilogram per hour for six hours
Number of subjects: 142
Study 7477166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 2401187 — intervention group
Group type: EXPERIMENTAL
Intervention: Lornoxicam (4 mg as a film-coated tablet) alone
Number of subjects: 18
Study 2401187 — intervention group
Group type: COMPARATOR
Intervention: Maalox (10 ml)
Number of subjects: 18
Study 2401187 — intervention group
Group type: COMPARATOR
Intervention: Solugastril (10 g)
Number of subjects: 18
Study 7322722 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed reminders
Number of subjects: 766
Study 7322722 — intervention group
Group type: COMPARATOR
Intervention: No mailed reminders (Control)
Number of subjects: 766
Study 6381007 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII) at 1.00 +/- 0.06 U insulin/h from 10 p.m. to 8 a.m.
Number of subjects: 7
Study 6381007 — intervention group
Group type: COMPARATOR
Intervention: Interruption of insulin infusion between 11 p.m. and 1 a.m.
Number of subjects: 7
Study 28857811 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary biomarker‐triggered KDIGO care bundle (early optimization of fluid status, maintenance of perfusion pressure, discontinuation of nephrotoxic agents)
Number of subjects: 121
Study 28857811 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary biomarker‐triggered KDIGO care bundle
Number of subjects: 121
Study 28857811 — intervention group
Group type: COMPARATOR
Intervention: Standard intensive care unit (ICU) care
Number of subjects: 121
Study 27788811 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (50 mg/kg) administered in the last 30 minutes of the operation.
Number of subjects: 70
Study 27788811 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal magnesium level).
Number of subjects: 70
Study 24709780 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 60
Study 24709780 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 60
Study 22450429 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 4819
Study 22450429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4819
Study 22450429 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C19 gain-of-function alleles
Number of subjects: 4819
Study 20055981 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus paclitaxel (CP) - carboplatin AUC5 + paclitaxel 175 mg/m2, d1q21
Number of subjects: 189
Study 20055981 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin plus pegylated liposomal doxorubicin (CLD) - carboplatin AUC5 + pegylated LD 45 mg/m2, d1q28
Number of subjects: 189
Study 20055981 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin plus paclitaxel (CP)
Number of subjects: 189
Study 20055981 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin plus pegylated liposomal doxorubicin (CLD)
Number of subjects: 189
Study 18076334 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone plus AFP retention
Number of subjects: 178
Study 18076334 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone without AFP retention
Number of subjects: 178